Lonoce Chiara, Salem Reda, Marusic Carla, Jutras Philippe V, Scaloni Andrea, Salzano Anna Maria, Lucretti Sergio, Steinkellner Herta, Benvenuto Eugenio, Donini Marcello
Laboratory of Biotechnology ENEA Research Center, Rome, Italy.
Département de phytologie, Centre de recherche et innovation des végétaux, Université Laval, Québec, Québec, Canada.
Biotechnol J. 2016 Sep;11(9):1209-20. doi: 10.1002/biot.201500628. Epub 2016 Jun 30.
Hairy root (HR) cultures derived from Agrobacterium rhizogenes transformation of plant tissues are an advantageous biotechnological manufacturing platform due to the accumulation of recombinant proteins in an otherwise largely protein free culture medium. In this context, HRs descending from transgenic Nicotiana tabacum plants were successfully used for the production of several functional mAbs with plant-type glycans. Here, we expressed the tumor-targeting monoclonal antibody mAb H10 in HRs obtained either by infecting a transgenic N. tabacum line expressing H10 with A. rhizogenes or a glyco-engineered N. benthamiana line (ΔXTFT) with recombinant A. rhizogenes carrying mAb H10 heavy and light chain cDNAs. Selected HR clones derived from both plants accumulated mAb H10 in the culture medium with similar yields (2-3 mg/L). N-glycosylation profiles of antibodies purified from HR supernatant revealed the presence of plant-typical complex structures for N. tabacum-derived mAb H10 and of GnGn structures lacking xylose and fucose for the ΔXTFT-derived counterpart. Both antibody glyco-formats exhibited comparable antigen binding activities. Collectively, these data demonstrate that the co-infection of ΔXTFT Nicotiana benthamiana with recombinant A. rhizogenes is an efficient procedure for the generation of stable HR cultures expressing the tumor-targeting mAb H10 with a human-compatible glycosylation profile, thus representing an important step towards the exploitation of root cultures for the production of 'next generation' human therapeutic antibodies.
发根(HR)培养物源自发根农杆菌对植物组织的转化,由于重组蛋白可在基本上不含蛋白质的培养基中积累,因此是一个具有优势的生物技术制造平台。在此背景下,源自转基因烟草植物的发根已成功用于生产几种带有植物型聚糖的功能性单克隆抗体(mAb)。在这里,我们在通过用发根农杆菌感染表达H10的转基因烟草品系或用携带mAb H10重链和轻链cDNA的重组发根农杆菌感染糖工程化的本氏烟草品系(ΔXTFT)而获得的发根中表达了肿瘤靶向单克隆抗体mAb H10。从这两种植物中获得的选定发根克隆在培养基中积累mAb H10的产量相似(2-3mg/L)。从发根上清液中纯化的抗体的N-糖基化谱显示,源自烟草的mAb H10存在植物典型的复杂结构,而源自ΔXTFT的对应物则存在缺乏木糖和岩藻糖的GnGn结构。两种抗体糖型均表现出相当的抗原结合活性。总体而言,这些数据表明,用重组发根农杆菌共感染ΔXTFT本氏烟草是生成稳定的发根培养物的有效方法,该培养物可表达具有人源兼容糖基化谱的肿瘤靶向mAb H10,因此代表了利用根培养物生产“下一代”人类治疗性抗体的重要一步。